Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2010 May;69(5):856-61.
doi: 10.1136/ard.2009.113043. Epub 2009 Nov 23.

Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variations

Mukundan Attur  1 , Hwa-Ying Wang, Virginia Byers Kraus, Jack F Bukowski, Nazneen Aziz, Svetlana Krasnokutsky, Jonathan Samuels, Jeffrey Greenberg, Gary McDaniel, Steven B Abramson, Kenneth S Kornman
Affiliations
Multicenter Study

Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variations

Mukundan Attur et al. Ann Rheum Dis. 2010 May.

Abstract

Background: A lack of biomarkers that identify patients at risk for severe osteoarthritis (OA) complicates development of disease-modifying OA drugs.

Objective: To determine whether inflammatory genetic markers could stratify patients with knee OA into high and low risk for destructive disease.

Methods: Genotype associations with knee OA severity were assessed in two Caucasian populations. Fifteen single nucleotide polymorphisms (SNPs) in six inflammatory genes were evaluated for association with radiographic severity and with synovial fluid mediators in a subset of the patients.

Results: Interleukin 1 receptor antagonist (IL1RN) SNPs (rs419598, rs315952 and rs9005) predicted Kellgren-Lawrence scores independently in each population. One IL1RN haplotype was associated with lower odds of radiographic severity (OR=0.15; 95% CI 0.065 to 0.349; p<0.0001), greater joint space width and lower synovial fluid cytokine levels. Carriage of the IL1RN haplotype influenced the age relationship with severity.

Conclusion: IL1RN polymorphisms reproducibly contribute to disease severity in knee OA and may be useful biomarkers for patient selection in disease-modifying OA drug trials.

PubMed Disclaimer

Conflict of interest statement

Competing interests: When the research was conducted JFB, NA and KSK were full-time employees and H-YW was a part-time consultant for Interleukin Genetics.

Figures

Figure 1
Figure 1
Influence of interleukin 1 receptor antagonist (IL1RN) haplotypes on the age relationship to severity of knee osteoarthritis (OA). (A) The figure stratifies patients with knee OA into thirds by age (<59, n=42; 59–68, n=40; >68, n=47). The numbers in each group are not exactly equal owing to the distribution of patients at the intersection of the groups. Patients within each age group were then stratified by carriage (dot-filled bars) or no carriage (grey-filled bars) of the IL1RN haplotype CTA of the single nucleotide polymorphisms (SNPs) rs419598/rs315952/rs9005. For each age strata and haplotype status, the frequency of severe radiographic knee OA (Kellgren–Lawrence (K–L) score >2) is plotted. (B, C) The joint space width (JSW) of each knee in patients with knee OA who do not (B) or do carry (C) the IL1RN CTA haplotype (rs419598/rs315952/rs9005) is plotted relative to age, and the regression line is shown for JSW relative to age. The JSW is significantly associated with age (p=0.0059) in patients with knee OA who do not carry the IL1RN CTA haplotype, but not associated with age (p=0.56) in patients who carried one or two copies of the CTA haplotype.
See this image and copyright information in PMC

References

    1. Zhai G, Hart DJ, Kato BS, et al. Genetic influence on the progression of radiographic knee osteoarthritis: a longitudinal twin study. Osteoarthr Cartil 2007;15:222–5 - PubMed
    1. Attur MG, Dave M, Cipolletta C, et al. Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type II IL-1 decoy receptor. Potential for pharmacological intervention. J Biol Chem 2000;275:40307–15 - PubMed
    1. Rogus J, Beck JD, Offenbacher S, et al. IL1B gene promoter haplotype pairs predict clinical levels of interleukin-1beta and C-reactive protein. Hum Genet 2008;123:387–98 - PubMed
    1. Kahraman S, Yilmaz R, Arici M, et al. IL-10 genotype predicts serum levels of adhesion molecules, inflammation and atherosclerosis in hemodialysis patients. J Nephrol 2006;19:50–6 - PubMed
    1. Reiner AP, Wurfel MM, Lange LA, et al. Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation. Arterioscler Thromb Vasc Biol 2008;28:1407–12 - PMC - PubMed

Publication types

MeSH terms

Substances